PPT Slide

• Current Market

  • Topical antibiotics: $600M
  • Combination products: $500M

• ISV novel antibiotics with broad bacterial sensitivities:

  • Gram positive and gram negative bacteria
  • Vancomycin resistant bacteria

ISV- 401, 402, and 403

Topical Ophthalmic Antibiotics

Previous slide

Next slide

Back to first slide

View graphic version